Dr. Levin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Columbia University Medical Center
New York, NY 10032
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2015 - 2018- Brigham and Women's HospitalInternship, Internal Medicine, 2014 - 2015
University of Massachusetts Medical SchoolClass of 2014
Certifications & Licensure
NY State Medical License 2017 - 2025
MA State Medical License 2014 - 2018- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Publications & Presentations
PubMed
- Safety, tolerability, and efficacy of diroximel fumarate in a cohort of Black patients with multiple sclerosis from the phase 3 EVOLVE-MS-1 study.Samuel F Hunter, John W Lindsey, Benjamin Osborne, Bethany Schreiber, Filipe Branco
Multiple Sclerosis and Related Disorders. 2024-11-01 - Lymphopenia is Not the Primary Therapeutic Mechanism of Diroximel Fumarate in Relapsing-Remitting Multiple Sclerosis: Subgroup Analyses of the EVOLVE-MS-1 Study.Barry A Singer, Sibyl Wray, Mark Gudesblatt, Barbara Bumstead, Tjalf Ziemssen
Neurology and Therapy. 2024-08-01 - 3 citationsFinal analysis of 379 pregnancy outcomes after exposure to dimethyl fumarate in a prospective international registry.Kerstin Hellwig, David Rog, Christopher McGuigan, Maria K Houtchens, Denise R Bruen
Multiple Sclerosis. 2024-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
